[{"id":"7a90c959-6200-482b-bd64-1fefe7058ce0","acronym":"","url":"https://clinicaltrials.gov/study/NCT04139057","created_at":"2023-02-15T22:00:37.795Z","updated_at":"2024-07-02T16:35:55.466Z","phase":"Phase 1/2","brief_title":"EBV-Specific Anti-PD1 TCR-T Cells in the Treatment of EBV-Positive NHSCC","source_id_and_acronym":"NCT04139057","lead_sponsor":"Xinqiao Hospital of Chongqing","biomarkers":" IL2","pipe":"","alterations":" ","tags":["IL2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EBV-specific anti-PD1 TCR-T cells"],"overall_status":"Recruiting","enrollment":" Enrollment 18","initiation":"Initiation: 03/01/2019","start_date":" 03/01/2019","primary_txt":" Primary completion: 01/01/2024","primary_completion_date":" 01/01/2024","study_txt":" Completion: 01/01/2024","study_completion_date":" 01/01/2024","last_update_posted":"2023-02-15"}]